{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T11:33:51Z","timestamp":1788089631412,"version":"build-2803163510"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,23]]},"DOI":"10.7759\/cureus.102177","type":"journal-article","created":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:52:51Z","timestamp":1769223171000},"source":"Crossref","is-referenced-by-count":2,"title":["Fulminant Clostridioides difficile Infection During Repeated High-Dose Cytarabine Consolidation for Acute Myeloid Leukemia: A Fatal Case"],"prefix":"10.7759","author":[{"given":"Eisaku","family":"Iwanaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotomo","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tokunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ichirou","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix1085","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)","volume":"66","author":"McDonald LC","year":"2018","unstructured":"McDonald LC, Gerding DN, Johnson S, et al.. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018, 66:1-48. 10.1093\/cid\/cix1085","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MCC.0b013e3282638879","article-title":"Fulminant Clostridium difficile colitis","volume":"13","author":"Adams SD","year":"2007","unstructured":"Adams SD, Mercer DW. Fulminant Clostridium difficile colitis. Curr Opin Crit Care. 2007, 13:450-5. 10.1097\/MCC.0b013e3282638879","journal-title":"Curr Opin Crit Care"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.2009.51","article-title":"Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality","volume":"144","author":"Sailhamer EA","year":"2009","unstructured":"Sailhamer EA, Carson K, Chang Y, et al.. Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality. Arch Surg. 2009, 144:433-9. 10.1001\/archsurg.2009.51","journal-title":"Arch Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1017\/ice.2015.54","article-title":"Outcomes of Clostridium difficile infection in hospitalized leukemia patients: a nationwide analysis","volume":"36","author":"Luo R","year":"2015","unstructured":"Luo R, Greenberg A, Stone CD. Outcomes of Clostridium difficile infection in hospitalized leukemia patients: a nationwide analysis. Infect Control Hosp Epidemiol. 2015, 36:794-801. 10.1017\/ice.2015.54","journal-title":"Infect Control Hosp Epidemiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile--more difficult than ever","volume":"359","author":"Kelly CP","year":"2008","unstructured":"Kelly CP, LaMont JT. Clostridium difficile--more difficult than ever. N Engl J Med. 2008, 359:1932-40. 10.1056\/NEJMra0707500","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v8.i5.398","article-title":"Characteristics of Clostridium difficile infection in patients hospitalized with myelodysplastic syndrome or acute myelogenous leukemia","volume":"8","author":"Shah K","year":"2017","unstructured":"Shah K, Curtin BF, Chu C, Hwang D, Flasar MH, von Rosenvinge E. Characteristics of Clostridium difficile infection in patients hospitalized with myelodysplastic syndrome or acute myelogenous leukemia. World J Clin Oncol. 2017, 8:398-404. 10.5306\/wjco.v8.i5.398","journal-title":"World J Clin Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab549","article-title":"Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults","volume":"73","author":"Johnson S","year":"2021","unstructured":"Johnson S, Lavergne V, Skinner AM, Gonzales-Luna AJ, Garey KW, Kelly CP, Wilcox MH. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis. 2021, 73:1029-44. 10.1093\/cid\/ciab549","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2021.102510","article-title":"Molecular epidemiology of endemic Clostridioides difficile infection in Japan","volume":"74","author":"Senoh M","year":"2022","unstructured":"Senoh M, Kato H. Molecular epidemiology of endemic Clostridioides difficile infection in Japan. Anaerobe. 2022, 74:102510. 10.1016\/j.anaerobe.2021.102510","journal-title":"Anaerobe"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.11406\/rinketsu.65.153","article-title":"Fulminant Clostridioides difficile infection during treatment with FLT3 inhibitor for acute myeloid leukemia (Article in Japanese)","volume":"65","author":"Yamamoto J","year":"2024","unstructured":"Yamamoto J, Watanabe O, Sako T, et al.. Fulminant Clostridioides difficile infection during treatment with FLT3 inhibitor for acute myeloid leukemia (Article in Japanese). Rinsho Ketsueki. 2024, 65:153-7. 10.11406\/rinketsu.65.153","journal-title":"Rinsho Ketsueki"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13216","article-title":"Successful treatment of fulminant Clostridioides difficile infection with emergent fecal microbiota transplantation in a patient with acute myeloid leukemia and prolonged, severe neutropenia","volume":"22","author":"Lee MS","year":"2020","unstructured":"Lee MS, Ramakrishna B, Moss AC, Gold HS, Branch-Elliman W. Successful treatment of fulminant Clostridioides difficile infection with emergent fecal microbiota transplantation in a patient with acute myeloid leukemia and prolonged, severe neutropenia. Transpl Infect Dis. 2020, 22:13216. 10.1111\/tid.13216","journal-title":"Transpl Infect Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5114\/ait.2019.89189","article-title":"Acute primary abdominal compartment syndrome due to Clostridium difficile induced toxic megacolon: a\u00a0case report and review of the literature","volume":"51","author":"Carmeliet T","year":"2019","unstructured":"Carmeliet T, Zach\u00e9e P, Dits H, Regenmortel N, Malbrain M. Acute primary abdominal compartment syndrome due to Clostridium difficile induced toxic megacolon: a\u00a0case report and review of the literature. Anaesthesiol Intensive Ther. 2019, 51:273-82. 10.5114\/ait.2019.89189","journal-title":"Anaesthesiol Intensive Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2019.12.029","article-title":"Fecal microbiota transplant decreases mortality in patients with refractory severe or fulminant Clostridioides difficile infection","volume":"18","author":"Cheng YW","year":"2020","unstructured":"Cheng YW, Phelps E, Nemes S, et al.. Fecal microbiota transplant decreases mortality in patients with refractory severe or fulminant Clostridioides difficile infection. Clin Gastroenterol Hepatol. 2020, 18:2234-2243.e1. 10.1016\/j.cgh.2019.12.029","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/447479-fulminant-clostridioides-difficile-infection-during-repeated-high-dose-cytarabine-consolidation-for-acute-myeloid-leukemia-a-fatal-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T02:52:52Z","timestamp":1769223172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/447479-fulminant-clostridioides-difficile-infection-during-repeated-high-dose-cytarabine-consolidation-for-acute-myeloid-leukemia-a-fatal-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.102177","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,23]]}}}